This inventor holds 1 USPTO granted patent. Top assignees: Kaneka Corporation, National Center for Global Health and Medicine. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023
Title: Masato Ibuki: Innovator in Cell Therapy
Introduction
Masato Ibuki is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of cell therapy, particularly through his innovative research and patents. His work focuses on the development of endodermal cell populations that can be utilized for optimal somatic cell preparations.
Latest Patents
Masato Ibuki holds 1 patent for his invention titled "Endodermal cell population, and method for producing cell population of any of three germ layers from pluripotent cell." The objective of this invention is to provide an endodermal cell population that reduces the content proportion of undifferentiated cells. This population contains endodermal cells that can differentiate into optimal somatic cells, which are essential for effective cell therapy preparations. The somatic cells derived from this endodermal population exhibit excellent therapeutic effects, making them valuable in medical applications.
Career Highlights
Throughout his career, Masato Ibuki has worked with notable organizations, including Kaneka Corporation and the National Center for Global Health and Medicine. His experience in these institutions has allowed him to advance his research and contribute to the field of cell therapy significantly.
Collaborations
Masato Ibuki has collaborated with esteemed colleagues such as Hitoshi Okochi and Shigeharu Yabe. These partnerships have fostered a collaborative environment that enhances innovation and research in cell therapy.
Conclusion
Masato Ibuki's contributions to the field of cell therapy through his innovative patent and collaborations highlight his role as a key inventor in this area. His work continues to pave the way for advancements in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile